Sexual recovery is complex, involving grieving, adjustments and adaptation
Sexual recovery during and after a women’s cancer diagnosis and treatment is as important as ensuring adequate nutrition, sleep and a healthy frame of mind. mCancerPartner recently talked to Sallie Foley, LMSW, AASECT, co-author of Sex Matters for Women, about sexual recovery after cancer for women who experience early menopause or menopause-like symptoms following cancer treatment.
mCancerPartner: In comparing natural menopause with early menopause brought on by cancer treatment, are there differences?
Ms. Foley: Yes. Natural menopause occurs over a number of years, so symptoms that can affect someone’s sexual experience – like vaginal dryness and thinning of vaginal tissues – tend to develop somewhat slowly. When early menopause or related symptoms happen because of chemotherapy, radiation or removal of the ovaries, symptoms that Continue reading →
Some of the risk factors for gallbladder cancer are a family history, being older, female, or being Mexican American.
Gallbladder cancer is rare. In fact, the American Cancer Society notes there will only be about 4,000 new cases of gallbladder cancer this year. Our gallbladder stores and secretes brownish liquid called bile which aids in the digestion of food. Since the gallbladder is hidden under the liver and not easily seen on imaging or felt, gallbladder cancer is usually discovered in the later stages. Only about 1 of 5 gallbladder cancers is found in the early stages, when the cancer has not yet spread beyond the gallbladder. Continue reading →
Medical student writes of his experiences in the Breast Cancer Clinic and says he learned more about life and the role of healthcare providers in caring for patients than he ever thought possible.
Editor’s note: ICE, or Initial Clinical Experience, is a program for new University of Michigan medical students. Instead of spending their first term only in lecture halls, they are assigned to shadow clinical faculty and other health professionals. This gives them early connections with patients and families and an understanding of the roles and responsibilities of all healthcare team members within the system.
Where is the line between disease and life drawn? This was a question I constantly thought about during my Initial Clinical Experience during my first term as a medical student. I remember the moment I found out I would be placed in the Breast Cancer Clinic and my feeling of dread. I was worried that so early in medical school I would come face-to-face with cancer, and through it, with death. Continue reading →
Blue light cystoscopy offers a significant advance in bladder tumor detection and, in Michigan, is only offered at the U-M Comprehensive Cancer Center. It uses a special dye, along with a blue light inside the patient to make cancer tumors more visible to surgeons. Left: tumors as seen with a traditional white light; right: the same tumors more visible with a dye and blue light.
mCancerPartner sat down recently with Cheryl Lee, M.D., a surgeon and professor of urology, to discuss blue light cystoscopy, a technology that significantly improves the detection of non-muscle invasive (early stage) cancer of the bladder during surgery. Dr. Lee’s research focuses on improving quality of life and surgical outcomes for bladder cancer patients. She is active with the Bladder Cancer Advocacy Network, where she has served as president of its Scientific Advisory Board and is currently a member of the Board of Directors. She is Past-Chairman of the Bladder Cancer Think Tank.
mCancerPartner: Can you talk about bladder cancer tumors and the challenges they present in regard to removing all the cancer. Continue reading →
It’s estimated that as many as 50%-75% of cancer deaths in the United States are caused by human behavior. If you think about that, it means our lifestyle choices can significantly impact a diagnosis of cancer. What can we do about cancer prevention?
Although not all cancers can be prevented, there are some measures we can take to greatly reduce our risk of getting a diagnosis of cancer.
Some patients with cancer experience a serious financial burden. A new study finds the burden is worse for patients without paid sick leave. In a survey of more than 1,300 patients with stage 3 colorectal cancer, researchers found that only 55% who were employed at the time of diagnosis retained their jobs after treatment. Patients who had paid sick leave were nearly twice as likely to retain their jobs as those without paid sick leave.
In the study, published in the Journal of the American Medical Association, the researchers found that patients without paid sick leave were more likely to report higher personal financial burden. This includes borrowing money, difficulties making credit card payments, reduced spending for food or clothing, or reduced recreational spending. Continue reading →
NOTICE: Except where otherwise noted, all articles are published under a Creative Commons Attribution 3.0 license. You are free to copy, distribute, adapt, transmit, or make commercial use of this work as long as you attribute the University of Michigan Health System as the original creator and include a link to this article.